Sign in to continue:

Thursday, April 23rd, 2026

Upland Software, Inc. Files Form 8-K with SEC Detailing Corporate Information and Security Listings April 2026

Upland Software, Inc. Issues Correction on Annual Report Sent to Shareholders

Austin, TX – April 22, 2026 – Upland Software, Inc. (NASDAQ: UPLD) has issued a significant update regarding its recently furnished Annual Report to Stockholders (ARS) for the fiscal year ended December 31, 2025. The company reported to the Securities and Exchange Commission (SEC) that it had inadvertently included preliminary and unaudited financial information for the three months ended March 31, 2026 in the ARS version distributed to shareholders and filed with the SEC.

Key Points of the Report

  • Incorrect Filing: The ARS sent to shareholders and filed with the SEC included data for Q1 2026 that was described by Upland as “preliminary, unaudited, and subject to change.”
  • Correction Process: The company has filed a corrected ARS with the SEC that attaches the accurate Annual Report on Form 10-K for the year ended December 31, 2025.
  • Shareholder Communication: Upland is also mailing a corrected copy of the ARS to any shareholders who requested the document in relation to the upcoming 2026 Annual Meeting of Stockholders.
  • Clarification on Financial Data: The preliminary Q1 2026 data included in the initial ARS:
    • Does not constitute an intentional disclosure of financial results for Q1 2026.
    • Is unaudited, subject to change, not reviewed by the company’s independent registered public accounting firm, and not finalized by Upland.
    • Should not be relied upon for any investment or decision-making purposes.
  • Upcoming Financial Reporting: Upland stated it intends to report its financial results for Q1 2026 in the ordinary course after completing its standard quarter-end financial close and review processes.

Important Information for Shareholders

  • This incident is potentially price sensitive as preliminary and unaudited financial figures for Q1 2026 were unintentionally disclosed to the market. Although the company has clarified that these numbers are not final and should not be relied upon, the mere presence of such data in public filings can cause confusion or volatility in the stock price.
  • Investors should be aware that, until Upland formally releases its Q1 2026 results, any financial figures relating to this period are not validated and may change materially.
  • The company’s swift correction and communication efforts may help to mitigate negative sentiment, but the situation underscores the importance of vigilance regarding official filings and the potential for administrative errors to impact investor perception.

What This Means for the Stock

This filing correction is highly relevant to investors and could move Upland’s share price in the short term. The unintentional release of preliminary financial data—even with disclaimers—can lead to speculation, rumors, and short-term volatility as market participants try to interpret what the numbers might mean for Upland’s financial trajectory. The company’s proactive approach in correcting the error and clarifying the nature of the data is positive, but until the official Q1 2026 results are released, uncertainty may linger.

Actionable Takeaways:

  • Exercise caution with any Q1 2026 figures from Upland until the official, audited results are published.
  • Monitor for the upcoming Q1 2026 earnings release for verified financial performance.
  • Shareholders with questions or needing the corrected ARS should contact Upland’s investor relations.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with financial advisors before making investment decisions. The author is not responsible for any actions taken based on the information provided herein.

View Upland Software, Inc. Historical chart here



QDRO Acquisition Corp. Announces $200 Million IPO, Targets Financial Services and Technology Sectors 12

QDRO Acquisition Corp. Announces Pricing of \$200 Million IP...

Prelude Therapeutics 2025 Annual Report: Precision Oncology Pipeline, Business Strategy, and Regulatory Overview

Prelude Therapeutics 2025 Annual Report: Key Highlights and ...

Clorox Completes Acquisition of GOJO Industries, Maker of Purell, Expanding Health and Hygiene Portfolio

Clorox Completes Acquisition of GOJO Industries, Makers of P...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today